Standardizing CYP 2D6 Genotype to Phenotype Translation: Consensus Recommendations from the Clinical Pharmacogenetics Implementation Consortium and Dutch Pharmacogenetics Working Group-Reference-Cited by-同舟云学术

Standardizing CYP 2D6 Genotype to Phenotype Translation: Consensus Recommendations from the Clinical Pharmacogenetics Implementation Consortium and Dutch Pharmacogenetics Working Group

Published:2019-10-24 Issue:1 Volume:13 Page:116-124
ISSN:1752-8054
Container-title:Clinical and Translational Science
language:en
Short-container-title:Clin Transl Sci

Author:

Caudle Kelly E.¹,Sangkuhl Katrin²,Whirl‐Carrillo Michelle²,Swen Jesse J.³,Haidar Cyrine E.¹,Klein Teri E.²,Gammal Roseann S.¹⁴,Relling Mary V.¹,Scott Stuart A.⁵⁶,Hertz Daniel L.⁷,Guchelaar Henk‐Jan³,Gaedigk Andrea⁸⁹

Affiliation:

1. Department of Pharmaceutical Sciences St. Jude Children's Research Hospital Memphis Tennessee USA

2. Department of Biomedical Data Science Stanford University Stanford California USA

3. Department of Clinical Pharmacy & Toxicology Leiden University Medical Center Leiden The Netherlands

4. Department of Pharmacy Practice MCPHS University School of Pharmacy Boston Massachusetts USA

5. Department of Genetics and Genomic Sciences Icahn School of Medicine at Mount Sinai New York New York USA

6. Sema4, a Mount Sinai venture Stamford Connecticut USA

7. Department of Clinical Pharmacy University of Michigan College of Pharmacy Ann Arbor Michigan USA

8. Division of Clinical Pharmacology, Toxicology, & Therapeutic Innovation Children's Mercy Kansas City Kansas City Missouri USA

9. School of Medicine University of Missouri‐Kansas City Kansas City Missouri USA

Funder

National Institutes of Health

PharmGKB

PharmVar

European Union's Horizon 2020

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cts.12692

Reference32 articles.

1. Physicochemical Properties, Biotransformation, and Transport Pathways of Established and Newly Approved Medications: A Systematic Review of the Top 200 Most Prescribed Drugs vs. the FDA-Approved Drugs Between 2005 and 2016

2. Clinical Pharmacogenetics Implementation Consortium Guideline for Cytochrome P450 ( CYP ) 2D6 Genotype and Atomoxetine Therapy

3. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and Tamoxifen Therapy

4. Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6 genotype and use of ondansetron and tropisetron

5. Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update

Cited by 381 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of CYP2D6 and CYP3A4 polymorphisms on aripiprazole and dehydroaripiprazole concentrations in patients undergoing long-acting treatment;Progress in Neuro-Psychopharmacology and Biological Psychiatry;2024-12

2. Long-read sequencing of CYP2D6 may improve psychotropic prescribing and treatment outcomes: A systematic review and meta-analysis;Journal of Psychopharmacology;2024-09-11

3. Prevalence of actionable pharmacogenetic variants and high‐risk drug prescriptions: A Swiss hospital‐based cohort study;Clinical and Translational Science;2024-09

4. Association of Polymorphic Cytochrome P450 Enzyme Pathways With Falls in Multimedicated Older Adults;Journal of the American Medical Directors Association;2024-09

5. Pharmacogenetic Approach to Tramadol Use in the Arab Population;International Journal of Molecular Sciences;2024-08-16